Aqueous Interleukin-6 (IL-6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age-Related Macular Degeneration

Journals Menu

Follow SCIRP

ISSN Print: 2165-7408
ISSN Online: 2165-7416
www.scirp.org/journal/ojoph
E-mail: ojoph@scirp.org

"Aqueous Interleukin-6 (IL-6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age-Related Macular Degeneration —Aqueous Cytokines after Bevacizumab"
written by Kakarla V. Chalam, Sandeep Grover, Sankarathi Balaiya, Ravi K. Murthy,
published by Open Journal of Ophthalmology, Vol.4 No.1, 2014

has been cited by the following article(s):

[1]	Minocycline and Diacetyl Minocycline Eye Drops Reduce Ocular Neovascularization in Mice
	… Vision Science & …, 2023

[2]	渗出性年龄相关性黄斑变性患者玻璃体液中 VEGF 的改变及与炎症的关系
	2018

[3]	Interleukin-6 participation in pathology of ocular diseases
	Pathophysiology, 2017

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top